Lombard Odier Asset Management (USA)’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-3,000
| Closed | -$711K | – | 213 |
|
|
2017
Q2 | $711K | Sell |
3,000
-333
| -10% | -$78.9K | 0.06% | 136 |
|
|
2017
Q1 | $1.15M | Sell |
3,333
-2,335
| -41% | -$802K | 0.11% | 119 |
|
|
2016
Q4 | $1.98M | Buy |
5,668
+213
| +4% | +$74.4K | 0.25% | 86 |
|
|
2016
Q3 | $2.19M | Buy |
5,455
+667
| +14% | +$268K | 0.2% | 112 |
|
|
2016
Q2 | $2.85M | Buy |
4,788
+132
| +3% | +$78.5K | 0.34% | 73 |
|
|
2016
Q1 | $2.34M | Buy |
4,656
+1,402
| +43% | +$706K | 0.32% | 99 |
|
|
2015
Q4 | $2.15M | Buy |
+3,254
| New | +$2.15M | 0.21% | 113 |
|